Click for new scientific resources and news about Corona[COVID-19]

Paper Information

Journal:   JOURNAL OF TORBAT HEYDARIYEH UNIVERSITY OF MEDICAL SCIENCES   WINTER 2018 , Volume 5 , Number 4 ; Page(s) 72 To 84.
 
Paper: 

MALAT1 AS A NEW BIOMARKER IN CANCER BIOLOGY

 
 
Author(s):  SOLEIMANI JELODAR RAHIM, GHASEMI BAHAREH, AHMADI JAVAD*, SARMADI MOHAMMAD
 
* DEPARTMENT OF LABORATORY SCIENCES, TORBAT HEYDARIYEH UNIVERSITY OF MEDICAL SCIENCES, TORBAT HEYDARIYEH, IRAN
 
Abstract: 

Background & Aim: Long non-coding RNAs are regulatory molecules that adjust many vital intracellular processes. MALAT1 is a long non-coding RNA playing a key role in the regulation of intracellular important processes and also involved in biology of various cancers. The purpose of this study was to investigate the functions of MALAT1 and overview of its role in cancer biology.
Methods: in this review, Elsevier, Science Direct, PubMed and Google Scholar databases were searched for the following keywords” “long non-coding RNA”, “MALAT1”, “cancer”and “metastasis”. The results were limited to the period of 1992-2016. Totally, 213 papers were chosen and at the end, 63 of them were included in the study.
Results: MALAT1 is involved in adjusting two important biological processes including regulation of gene expression and alternative splicing. MALAT1 plays a role in the regulation of cell cycle, early stages of cancer metastasis, activation of p53 and its target genes, expression and activity of oncogenic transcription factor B-MYB, regulating the activity of E2F1 transcription factor, apoptosis pathway, regulation of hyperglycemia and many other processes.
Conclusion: Discussing about effect of on regulation of cellular critical processes, this study tries to better understand the mechanisms of cancer progression by this regulatory RNA. Comprehending the role of these regulatory RNAs and exploring their influence on biology of various cancers can be helpful in prognosis, predicting response to treatment, staging of disease and treatment of malignancies.
Furthermore, these molecules could potentially be proposed as novel therapeutic targets.

 
Keyword(s): LONG NON-CODING RNA, MALAT1, CANCER, METASTASIS
 
 
References: 
  • Not Registered.
  •  
 
+ Click to Cite.
APA: Copy

SOLEIMANI JELODAR, R., & ghasemi, B., & AHMADI, J., & SARMADI, M. (2017). MALAT1 AS A NEW BIOMARKER IN CANCER BIOLOGY. JOURNAL OF TORBAT HEYDARIYEH UNIVERSITY OF MEDICAL SCIENCES, 5(4 ), 72-84. https://www.sid.ir/en/journal/ViewPaper.aspx?id=569594



Vancouver: Copy

SOLEIMANI JELODAR RAHIM, ghasemi Bahareh, AHMADI JAVAD, SARMADI MOHAMMAD. MALAT1 AS A NEW BIOMARKER IN CANCER BIOLOGY. JOURNAL OF TORBAT HEYDARIYEH UNIVERSITY OF MEDICAL SCIENCES. 2017 [cited 2021May18];5(4 ):72-84. Available from: https://www.sid.ir/en/journal/ViewPaper.aspx?id=569594



IEEE: Copy

SOLEIMANI JELODAR, R., ghasemi, B., AHMADI, J., SARMADI, M., 2017. MALAT1 AS A NEW BIOMARKER IN CANCER BIOLOGY. JOURNAL OF TORBAT HEYDARIYEH UNIVERSITY OF MEDICAL SCIENCES, [online] 5(4 ), pp.72-84. Available: https://www.sid.ir/en/journal/ViewPaper.aspx?id=569594.



 
 
Persian Abstract Yearly Visit 32
 
Latest on Blog
Enter SID Blog